The numbers behind private markets are telling a more complicated story

Private-market headlines often come down to one big number.

$1.4 trillion. $40 billion. $22 billion. $6.3 billion.

The numbers grab attention, but they do not always tell the same story.

A valuation can be measured before or after new money comes in. A tender offer can establish a price for existing shares without putting fresh capital into the company. An acquisition premium can look very different depending on which share-price benchmark is used.

That distinction matters, particularly when private companies are being valued at levels that would have seemed extraordinary just a few years ago.

Here are six numbers that stood out this week, and what sits underneath each one.

$1.4 trillion: OpenAI’s valuation comes before the new money

OpenAI is reportedly seeking at least $30 billion in new funding at a valuation of roughly $1.4 trillion before the new money, according to Bloomberg reporting relayed by Reuters.

That wording is important.

The $1.4 trillion figure is a pre-money valuation, meaning the new investment has not yet been added to the company’s value.

If the reported $30 billion investment goes ahead on those terms, the implied post-money valuation would be around $1.43 trillion.

That also changes how the new valuation compares with OpenAI’s previous financing.

In March, OpenAI was valued at $852 billion post-money. On a rough pre-money to post-money adjusted comparison, the reported $1.4 trillion figure represents an increase of about 64%.

But there is an important caveat.

The financing is reportedly still at an early stage, and the terms could change. Bloomberg has also described the transaction as bridge financing rather than an IPO.

Meanwhile, Forge’s indicative price on October 1 implied a value of around $1.18 trillion, based on secondary-market activity.

That is another reminder that different private-market pricing mechanisms can produce very different numbers.

The headline: $1.4 trillion.

The detail: It is a reported pre-money valuation, not the amount the company would be worth after the new investment is added.

$40 billion: Kalshi’s valuation comes as the company faces a regulatory fight

Kalshi is reportedly finalizing a financing at a valuation of around $40 billion, with an IPO potentially coming as soon as next year.

Forge lists a $1.1 billion Series G at a $40 billion post-money valuation dated September 17.

The two reports may refer to the same financing, although they describe its timing and status differently.

The valuation also comes against a complicated regulatory backdrop.

Five days before the latest financing reports, the 6th US Circuit Court of Appeals ruled that Kalshi had not shown that its sports contracts qualified as “swaps” under federal commodities law.

The court upheld the authority of Ohio and Tennessee to regulate the contracts under state gambling laws.

The reporting does not establish how that ruling affects the financing itself.

That distinction is worth keeping in mind. A company’s valuation and its regulatory situation can move alongside each other without one necessarily explaining the other.

For investors, the bigger question is how Kalshi’s business develops as it navigates regulation and considers a potential public listing.

The headline: $40 billion.

The detail: The financing reports and the regulatory ruling are separate developments, and the available reporting does not establish a direct connection between them.

$22 billion: ElevenLabs doubled its valuation through an employee tender

ElevenLabs has completed a $300 million employee tender offer at a $22 billion valuation.

That is twice the company’s $11 billion valuation from February.

At first glance, the jump looks straightforward.

But a tender offer is different from a conventional funding round.

In a tender, existing shareholders sell shares to approved buyers. The money can therefore go to the employees or other selling shareholders rather than directly into the company.

That makes the transaction different from a primary financing, where investors put new money into the business in exchange for newly issued shares.

The latest tender is also the company’s second employee tender.

In September 2025, employees sold shares in a transaction that valued ElevenLabs at $6.6 billion, with $100 million changing hands.

The latest transaction therefore shows how quickly the price attached to the company’s shares has moved across private transactions.

But it should not automatically be interpreted as the same thing as raising $300 million of fresh capital for the company.

The headline: $22 billion.

The detail: The valuation came from a secondary employee tender, where existing shares changed hands.

$6.3 billion: The Amex GBT deal shows why the benchmark matters

Long Lake completed its $6.3 billion all-cash acquisition of American Express Global Business Travel.

Shareholders received $9.50 per share.

The company described that price as a 65.1% premium to the 30-day VWAP from the date of the merger agreement.

VWAP stands for volume-weighted average price.

Why does that matter?

Because a premium depends entirely on what you compare it with.

A 65% premium to a 30-day average is not necessarily a 65% premium to the stock’s last closing price before the announcement.

Those are different benchmarks and can produce different results.

The deal also marks a change in Amex GBT’s status. Following the acquisition, the company has left the NYSE and is now privately held.

Long Lake’s backers include General Catalyst, Thrive and Elad Gil, while Koch Equity Development provided equity financing.

The headline: $6.3 billion.

The detail: The reported 65.1% premium was measured against a specific 30-day VWAP, not simply the last traded share price.

The SEC is considering another path into accredited-investor status

Another number in this week’s private-market story is much smaller but potentially significant.

The SEC has asked for public comment on possible new routes for individuals to qualify as accredited investors.

The proposed pathways include a FINRA-developed exam as well as certain professional qualifications, including:

  • CPA license
  • CFA charter
  • CFP certification
  • Series 79
  • Series 86
  • Series 87

The details reported about the potential exam include 75 multiple-choice questions, a two-hour testing period and a $100 fee, with a passing result reportedly valid for 10 years.

However, those exam details come from law-firm and press reports rather than directly from the SEC release.

And there is another important point: this is a request for comment, not a final rule.

The SEC has not yet decided to designate these credentials or introduce the proposed exam.

Under current rules, individuals generally qualify as accredited investors through income, net worth or certain existing professional credentials. The commonly cited financial thresholds include annual income above $200,000, or $300,000 with a spouse, or net worth above $1 million excluding a primary residence.

If the proposed changes eventually move forward, they could broaden the routes through which individuals gain access to private-market investments.

But for now, they remain under consideration.

The headline: $100.

The detail: That is the reported potential exam fee, not a new cost or requirement that has already been adopted.

The FTC is investigating OpenAI and Anthropic

The final development brings the focus back to AI.

An FTC spokesperson confirmed that an investigation involving AI companies, including OpenAI and Anthropic, is underway.

The investigation concerns potential consumer harms linked to AI.

Reports have also said that FTC Chair Andrew Ferguson is preparing civil investigative demands that could require executives to provide documents and testify about the safety of their models.

But those demands were described as being prepared, rather than already issued.

That distinction matters.

The existence of an investigation does not mean that regulators have reached a conclusion about wrongdoing. It means the agency is examining the issue.

Neither company had responded to requests for comment from Axios or ABC at the time of their reports.

For companies commanding some of the world’s highest private valuations, regulatory scrutiny is becoming another factor investors have to watch alongside growth, funding requirements and competition.

Why these numbers need context

The common thread across all six stories is simple:

A headline number is rarely the whole story.

A $1.4 trillion valuation can be pre-money.

A $22 billion valuation can come from employees selling existing shares.

A $40 billion financing can be reported at different stages depending on the source.

A 65% acquisition premium can depend on the benchmark used.

And a regulatory proposal can be reported long before it becomes an actual rule.

This is particularly important in private markets, where pricing is less transparent than it is in public markets.

Private-company valuations can come from funding rounds, tender offers, secondary transactions or indicative pricing. These transactions may involve limited numbers of buyers and sellers, meaning they do not necessarily represent a continuously traded market price.

That does not make the numbers meaningless.

It means they need to be read carefully.

The number gets the headline. The terms tell you what the number actually means.